logo
Select company
Select metric
43.88%Gross Profits to Assets
VS
Market
84
Sector
82
Industry
89
History
68
$ 3.16Close
$ 1.37 - $ 4.01 52-Week Range
Ticker Information

Ticker

AKBA

Company Name

AKEBIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AKEBIA THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AKBA - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 345.6M$ 151.66M43.88%
3/31/2025$ 310.19M$ 125.71M40.53%
12/31/2024$ 220.67M$ 97M43.96%
9/30/2024$ 207.14M$ 108.4M52.33%
6/30/2024$ 220.2M$ 109.17M49.58%
3/31/2024$ 225.48M$ 121.66M53.96%
12/31/2023$ 241.7M$ 120.47M49.84%
9/30/2023$ 235M$ 141.16M60.07%
6/30/2023$ 253.71M$ 128.14M50.5%
3/31/2023$ 276.86M$ 198.09M71.55%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 5.52%.
  • Over the past 5 years, AKEBIA THERAPEUTICS INC's average GPA has been 34.2%.
  • The median GPA for AKEBIA THERAPEUTICS INC during this period was 42.21%
  • AKEBIA THERAPEUTICS INC reached its highest GPA over the past 5 years at 71.55%.
  • The lowest GPA recorded by AKEBIA THERAPEUTICS INC in the same timeframe -6.95%

AKEBIA THERAPEUTICS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
STOK : STOKE THERAPEUTICS INC 51.99%DNA : GINKGO BIOWORKS HOLDINGS INC 14.81%DAWN : DAY ONE BIOPHARMACEUTICALS INC 33.99%GERN : GERON CORP 28.96%IOVA : IOVANCE BIOTHERAPEUTICS INC 5.48%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 7%KROS : KEROS THERAPEUTICS INC 30.75%CRMD : CORMEDIX INC 45.99%NAGE : NIAGEN BIOSCIENCE INC 80.85%ZYME : ZYMEWORKS INC 30.09%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for AKEBIA THERAPEUTICS INC is calculated as follows: GP [ $ 37.34M ] / Assets [ $ 676.14M ]
(=) GPA [ 5.52% ]

AKBA - Gross Profits to Assets, Last 5 years

-6.95%

Minimum

Mar 31, 2021

71.55%

Maximum

Mar 31, 2023

34.2%

Average

42.21%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.15% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.14K
min-50.32%
max83.98%
average20.15%
median15.34%
std19.95%